Cargando…
Personalised immunotherapy in sepsis: a scoping review protocol
INTRODUCTION: Sepsis, a life-threatening organ dysfunction syndrome occurring in the context of severe infections, remains a major burden on global health with high morbidity and high mortality rates. Despite recent advances in the understanding of its pathophysiology, the treatment of sepsis remain...
Autores principales: | Slim, Marleen A, van Mourik, Niels, Dionne, Joanna C, Oczkowski, Simon J W, Netea, M G, Pickkers, Peter, Giamarellos-Bourboulis, Evangelos J, Müller, Marcella C A, van der Poll, Tom, Wiersinga, W Joost, Vlaar, Alexander P J, van Vught, Lonneke A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9086601/ https://www.ncbi.nlm.nih.gov/pubmed/35534059 http://dx.doi.org/10.1136/bmjopen-2021-060411 |
Ejemplares similares
-
ImmunoSep (Personalised Immunotherapy in Sepsis) international double-blind, double-dummy, placebo-controlled randomised clinical trial: study protocol
por: Kotsaki, Antigone, et al.
Publicado: (2022) -
Inflammatory biomarkers at hospital discharge are associated with readmission and death in patients hospitalized for COVID-19
por: Slim, Marleen A., et al.
Publicado: (2021) -
Real-world Evidence of the Effects of Novel Treatments for COVID-19 on Mortality: A Nationwide Comparative Cohort Study of Hospitalized Patients in the First, Second, Third, and Fourth Waves in the Netherlands
por: Slim, Marleen A, et al.
Publicado: (2022) -
Critically ill patients demonstrate large interpersonal variation in intestinal microbiota dysregulation: a pilot study
por: Lankelma, Jacqueline M., et al.
Publicado: (2016) -
Time since SARS-CoV-2 infection and humoral immune response following BNT162b2 mRNA vaccination
por: Appelman, Brent, et al.
Publicado: (2021)